Surmodics, Inc. (NASDAQ:SRDX) Stake Boosted by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Surmodics, Inc. (NASDAQ:SRDX) by 165.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 30,000 shares of the company’s stock after acquiring an additional 18,692 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Surmodics were worth $1,188,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in the business. Modus Advisors LLC acquired a new stake in shares of Surmodics during the 4th quarter worth approximately $40,000. Quest Partners LLC increased its position in Surmodics by 107,100.0% in the third quarter. Quest Partners LLC now owns 1,072 shares of the company’s stock worth $42,000 after buying an additional 1,071 shares during the period. R Squared Ltd bought a new stake in Surmodics in the fourth quarter valued at $55,000. SG Americas Securities LLC boosted its holdings in shares of Surmodics by 22.1% during the fourth quarter. SG Americas Securities LLC now owns 6,940 shares of the company’s stock valued at $275,000 after acquiring an additional 1,255 shares during the period. Finally, Algert Global LLC grew its position in shares of Surmodics by 29.9% during the third quarter. Algert Global LLC now owns 17,820 shares of the company’s stock worth $691,000 after acquiring an additional 4,098 shares during the last quarter. Institutional investors own 96.63% of the company’s stock.

Surmodics Stock Performance

Shares of SRDX opened at $30.48 on Thursday. The firm has a market capitalization of $435.74 million, a PE ratio of -30.18 and a beta of 1.19. The company has a quick ratio of 4.29, a current ratio of 5.45 and a debt-to-equity ratio of 0.26. The firm has a 50-day moving average price of $33.11 and a 200 day moving average price of $36.87. Surmodics, Inc. has a 52-week low of $25.17 and a 52-week high of $42.44.

Surmodics (NASDAQ:SRDX) last posted its quarterly earnings data on Thursday, February 6th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.04. Surmodics had a negative net margin of 11.48% and a negative return on equity of 4.39%. On average, sell-side analysts anticipate that Surmodics, Inc. will post 0.2 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on SRDX. StockNews.com started coverage on shares of Surmodics in a research report on Monday, February 3rd. They issued a “hold” rating on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Surmodics in a report on Thursday, January 30th. Finally, Lake Street Capital raised Surmodics from a “hold” rating to a “buy” rating and set a $43.00 price objective for the company in a report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Surmodics has an average rating of “Hold” and an average price target of $50.00.

Surmodics Company Profile

Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD).